Exploring PRM-A as a novel glycan-targeted therapy for SARS-CoV-2 inhibition
HIV, Ebola and most recently, COVID-19 viruses have had an enormous impact on our societies world-wide. All these viruses are ...
Tag: Glycan
LSHTM researchers receive £2m funding to develop novel vaccines, diagnostics and therapeutics
Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been awarded £2m funding through the UK Research ...
Unlocking the power of lectins: BOA emerges as a potent weapon against all SARS-CoV-2 variants
In a recent article published in Proceedings of the National Academy of Sciences, researchers evaluate the potency of antiviral lectins against ...
Scientists identify molecules in mucus that can block cholera infection
MIT researchers have identified molecules found in mucus that can block cholera infection by interfering with the genes that cause ...
Potent hypervalent nanoparticles against HIV, Lassa and SARS-CoV-2 variants
In a recent study published in the journal Advanced Science, researchers developed molecularly imprinted nanoparticles (nanoMIPs) with broad-spectrum activity against ...
What is the role of N-glycans and calnexin-calreticulin chaperones in SARS-CoV-2 spike maturation?
A recent study published in Science Advances showed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike N-glycosylation patterns, intracellular lectins, as ...
Synthetic mucin gels against HIV-1 and HSV-2 transmission
In a recent study published in the Advanced Science journal, researchers assessed the effectiveness of synthetic mucin gels in the ...
Exploration of glycan shield structure of sarbecoviruses provides new insights into developing pan-coronavirus vaccines
A recent study posted on the bioRxiv* preprint server explored the glycan shield diversity of sarbecoviruses, furthering the knowledge for ...
How natural alterations inside the SARS-CoV-2 glycan barrier affect spike protein dynamics
In a recent article published in the bioRxiv* preprint server, researchers explored how the natural alterations inside the severe acute respiratory ...
Study paves new way to develop a predictive biomarker for TRAIL therapy
A cytokine named TRAIL binds to TRAIL receptors and kills cancer cells, but not normal cells. Therefore, various anticancer drugs ...
